XML 142 R19.htm IDEA: XBRL DOCUMENT
v3.25.1

Stock Options | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2025 | Dec. 31, 2024
Stock Options [Abstract] |  |
STOCK OPTIONS | 13. STOCK OPTIONS The Company has not granted any options during three months ended March 31, 2025 and 2024. The Company’s most recent option grant was in 2022 that 76,190 shares (post-split) of common stock were granted to employees and certain consultants. The weighted average grant date fair value of options granted in 2022 was $27.9 (post-split). There are 386,021 options available for grant under the 2016 Equity Incentive Plan as of December 31, 2024. Compensation costs associated with the Company’s stock options are recognized, based on the grant-date fair values of these options over vesting period. As of March 31, 2025 and December 31, 2024, there were no unvested options. Options issued and outstanding as of March 31, 2025, and their activities during the year then ended are as follows:
|  |  |  |  | Weighted- |  |  | Weighted- |  |  |  |
|  |  |  |  | Average |  |  | Average |  |  |  |
|  | Number of |  |  | Exercise |  |  | Contractual |  |  |  |
|  | Underlying Shares (post-split) |  |  | Price Per Share (post-split) |  |  | Life Remaining in Years |  |  | Aggregate Intrinsic Value |
Outstanding as of January 1, 2025 |  |  | 258,710 |  |  | $ | 27.9 |  |  |  | 6.74 |  |  |  | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding as of March 31, 2025 |  |  | 258,710 |  |  |  | 27.9 |  |  |  | 6.50 |  |  | $ | - |
Exercisable as of March 31, 2025 |  |  | 258,710 |  |  |  | 27.9 |  |  |  | 6.50 |  |  | $ | - |
Vested and expected to vest |  |  | 258,710 |  |  | $ | 27.9 |  |  |  | 6.50 |  |  | $ | - |
| 13. STOCK OPTIONS The Company has not granted any options during years ended December 31, 2024 and 2023. The Company’s most recent option grant was in 2022 that 76,190 shares (post-split) of common stock were granted to employees and certain consultants. The weighted average grant date fair value of options granted in 2022 was $27.9 (post-split). There are 386,021 options available for grant under the 2016 Equity Incentive Plan as of December 31, 2024. Compensation costs associated with the Company’s stock options are recognized, based on the grant-date fair values of these options over vesting period. As of December 31, 2024 and 2023, there were no unvested options. Options issued and outstanding as of December 31, 2024, and their activities during the year then ended are as follows:
|  |  |  |  | Weighted- |  |  | Weighted- |  |  |  |
|  |  |  |  | Average |  |  | Average |  |  |  |
|  | Number of |  |  | Exercise |  |  | Contractual |  |  |  |
|  | Underlying Shares (post-split) |  |  | Price Per Share (post-split) |  |  | Life Remaining in Years |  |  | Aggregate Intrinsic Value |
Outstanding as of January 1, 2024 |  |  | 258,710 |  |  | $ | 27.9 |  |  |  | 7.74 |  |  |  | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding as of December 31, 2024 |  |  | 258,710 |  |  |  | 27.9 |  |  |  | 7.74 |  |  | $ | - |
Exercisable as of December 31, 2024 |  |  | 258,710 |  |  |  | 27.9 |  |  |  | 7.74 |  |  | $ | - |
Vested and expected to vest |  |  | 258,710 |  |  | $ | 27.9 |  |  |  | 6.74 |  |  | $ | - |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration